神经退行性变
生物
神经毒性
肌萎缩侧索硬化
失智症
细胞生物学
疾病
痴呆
化学
病理
医学
毒性
有机化学
作者
Sun Joo Cha,Seongsoo Lee,Hyun‐Jun Choi,Yeo Jeong Han,Yu‐Mi Jeon,Myungjin Jo,Shinrye Lee,Minyeop Nahm,Su Min Lim,Seung Hyun Kim,Hyung‐Jun Kim,Kiyoung Kim
标识
DOI:10.1016/j.devcel.2022.02.022
摘要
Summary
Fused in sarcoma (FUS) is a DNA/RNA-binding protein that is involved in DNA repair and RNA processing. FUS is associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the molecular mechanisms underlying FUS-mediated neurodegeneration are largely unknown. Here, using a Drosophila model, we showed that the overexpression of glutathione transferase omega 2 (GstO2) reduces cytoplasmic FUS aggregates and prevents neurodegenerative phenotypes, including neurotoxicity and mitochondrial dysfunction. We found a FUS glutathionylation site at the 447th cysteine residue in the RanBP2-type ZnF domain. The glutathionylation of FUS induces FUS aggregation by promoting phase separation. GstO2 reduced cytoplasmic FUS aggregation by deglutathionylation in Drosophila brains. Moreover, we demonstrated that the overexpression of human GSTO1, the homolog of Drosophila GstO2, attenuates FUS-induced neurotoxicity and cytoplasmic FUS accumulation in mouse neuronal cells. Thus, the modulation of FUS glutathionylation might be a promising therapeutic strategy for FUS-associated neurodegenerative diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI